Clinical research

A prospective randomised study of the paclitaxel-coated balloon catheter in bifurcated coronary lesions (BABILON trial): 24-month clinical and angiographic results

EuroIntervention 2014;10:50-57. DOI: 10.4244/EIJV10I1A10

Jose Ramon Lopez-Minguez
José Ramón López Mínguez1*, MD, PhD; Juan Manuel Nogales Asensio1, MD, PhD; Luis Javier Doncel Vecino1, MD; Jorge Sandoval2, MD; Sebastián Romany3, MD; Pedro Martínez Romero4, MD, José Antonio Fernández Díaz5, MD; Javier Fernández Portales3, MD, PhD; Reyes González Fernández1, MD, PhD; Ginés Martínez Cáceres1, MD; Antonio Merchán Herrera1, MD, PhD; Fernando Alfonso Manterola2, MD, PhD; on behalf of the BABILON Investigators
1. Hospital Universitario Infanta Cristina, Badajoz, Spain; 2. Hospital Universitario Clínico de San Carlos, Madrid, Spain; 3. Hospital San Pedro de Alcántara, Cáceres, Spain; 4. Hospital Puerto Real, Cádiz, Spain; 5. Hospital Universitario Clínica Puerta

Aims: Paclitaxel drug-eluting balloons (pDEB) could be an attractive option to minimise side branch (SB) restenosis in bifurcated coronary lesions. We compared angiographic and clinical o

Sign in to read and download the full article

Forgot your password?

No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

bifurcation lesionsdrug-coated balloondrug-eluting balloonclinical research
Read next article
Drug-eluting stents and bare metal stents in patients with NSTE-ACS: 2-year outcome from the randomised BASKET-PROVE trial

Latest news